In addition, using immunohistochemistry (IHC), we also observed that simvastatin treatment increased AMPK phosphorylation, reduced STAT3 phosphorylation and decreased Skp2 expression in tumor tissues (Figure 7d). Here, SKP2 is linked to neoplasm.